Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

Clinical trial NCT07033598 · RECRUITING

Trial details

NCT number: NCT07033598
Sponsor: Theradex
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myelomonocytic, Chronic

Start date: 2026-01-01
Primary completion: 2028-07-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.